Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Antheia uses synthetic biology to produce biosynthetic KSMs and APIs for essential medicines through engineered microbial fermentation.
Integrated Bio develops multimodal biological datasets and AI for drug discovery, focusing on therapeutics for age-related diseases.
Siren Biotechnology focuses on combining AAV gene therapy with cytokine immunotherapy to develop innovative treatments for cancer.
Alveo is a pre-clinical stage medical diagnostics company .
Iantrek develops technology for minimally invasive microinvasive glaucoma surgery.
10x Science offers an AI software that analyzes protein data to characterize molecular structures and support biopharmaceutical research.
Tacit Therapeutics created RNA-targeting treatments for devastating diseases.
Trial Library is an oncology clinical trials company.
Curve Biosciences is a biotechnology company that focuses on precision medicine for chronic diseases.
Tahoe Therapeutics is a biotechnology company that develops AI models of human cells to enhance drug discovery.
Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.
OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.
Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response.
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
Manus Bio develops an advanced fermentation technology to recreate plant processes in microorganisms.
OverT Bio operates as a biotech company that provide cell therapy for cancers.
Deep Learning x Synthetic Biology for Novel Protein Therapeutics
Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.
Catena Biosciences is a biotechnology company that offers protein conjugation, building biologic structures, and medical research.
Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides at an unprecedented scale.
Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.
Aperiam Bio partners with enzyme engineers to create and share stabilized, solubilized, and catalytically optimized proteins.
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
Range Biotechnologies is creating tools to enable personalized health through translational proteomics.
Civilization Ventures has invested in 50 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Civilization Ventures's top investment sectors include Biotechnology, Health Care, Life Science, Therapeutics, Medical. The firm invests across 23 different industry categories.
Among tracked funding rounds, Rocket Pharmaceuticals received $165.0M in a Post-IPO Equity round. Civilization Ventures's total known invested capital is $1.2B.
Civilization Ventures's average investment size is $24.4M across its portfolio of 50 companies.
Recent Civilization Ventures portfolio additions include Antheia, Integrated Biosciences, Siren Biotechnology, Alveo Technologies, Iantrek. These companies were founded in 2020 or later.